Brief: SSY Obtains Approvals For Drug Production & Registration For 0.3Ml Timolol Maleate Eye Drops From NMPA
09/06/2025 12:42
June 9 (Reuters) - SSY Group Ltd 2005.HK: OBTAINS APPROVALS FOR DRUG PRODUCTION & REGISTRATION FOR 0.3ML TIMOLOL MALEATE EYE DROPS IN UNIT DOSE PACKAGING (0.5% AND 0.25%) FROM NMPA Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth